GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)

Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Drug: GM604;   Drug: Placebo comparator
Sponsors:   Genervon Biopharmaceuticals, LLC;   Columbia University;   Massachusetts General Hospital
Completed - verified August 2016